Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCash Due from BankCommon EquityFed Funds SoldGoodwillGoodwill & IntangiblesIntangiblesInterest DepositsLiabilities and Shareholders EquityLoans - GrossLoans - Loss AllowanceLoans - NetLong-Term InvestmentsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Retained EarningsSecurities - Held-to-maturitySecurities - Mortgage Backed SecuritiesSecurities - TradableShareholder's EquityShares OutstandingTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lcnb (LCNB) Cash & Equivalents (2019 - 2025)

Historic Cash & Equivalents for Lcnb (LCNB) over the last 13 years, with Q3 2025 value amounting to $35.9 million.

  • Lcnb's Cash & Equivalents fell 891.2% to $35.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.9 million, marking a year-over-year decrease of 891.2%. This contributed to the annual value of $35.7 million for FY2024, which is 1001.69% down from last year.
  • According to the latest figures from Q3 2025, Lcnb's Cash & Equivalents is $35.9 million, which was down 891.2% from $49.8 million recorded in Q2 2025.
  • In the past 5 years, Lcnb's Cash & Equivalents ranged from a high of $49.8 million in Q2 2025 and a low of $1.1 million during Q4 2021
  • Moreover, its 5-year median value for Cash & Equivalents was $33.0 million (2024), whereas its average is $31.6 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first tumbled by 7101.75% in 2021, then surged by 194882.67% in 2022.
  • Lcnb's Cash & Equivalents (Quarter) stood at $1.1 million in 2021, then soared by 1948.83% to $22.7 million in 2022, then skyrocketed by 74.98% to $39.7 million in 2023, then decreased by 10.02% to $35.7 million in 2024, then grew by 0.34% to $35.9 million in 2025.
  • Its Cash & Equivalents stands at $35.9 million for Q3 2025, versus $49.8 million for Q2 2025 and $37.7 million for Q1 2025.